In recent months, the US FDA has released several guidance documents related to SaMD, SiMD and connected medical devices that are changing the regulatory landscape for both new and experienced medical device companies. This 90-minute webinar provides an overview of these landscape shifts and a panel discussion on the practical implications and applications with experienced regulatory, quality, cybersecurity and software development professionals who deal with them every day. Hear the lessons we've learned from our collective experience working with hundreds of companies.

This webinar discusses software and cybersecurity documentation, quality management systems, and how to be FDA compliant with these new guidelines.

The webinar includes:
Presentations from MCRA's experts on the new FDA guidelines
Roundtable discussion with MCRA experts and Innolitics executives
Live question and answer session

Speakers:
Nikki Batista: MCRA – Vice President, Digital Health and Regulatory Affairs
Alex Cadotte, Ph.D.: MCRA – Senior Director, Digital Health and Imaging Regulatory Affairs
Lauren White, MBA, CISSP: MCRA – Director of IT and Security
Dan Goldstein: MCRA – Senior Director, Quality Assurance
J. David Giese: Innolitics – CEO and co-founder
Yujan Shresha, MD: Innolitics – CTO and co-founder

About MCRA:
MCRA is the leading therapy-focused CRO and advisory firm, and the pioneer in integrating six core services to support the medical device industry: regulatory affairs, clinical research, reimbursement and market access, quality assurance, healthcare compliance and cybersecurity. Our global footprint with leadership in the top three medical device markets, US, Europe and Japan, integrated services expertise and deep therapeutic knowledge makes us the leading partner to commercialize medical innovation around the world .

Read more about MCRA on our website: www.mcra.com.

Please take the opportunity to connect and share this video with your friends and family if you find it helpful.